P3 Health Partners Announces Select Preliminary Fourth Quarter and Full Year 2021 Results, and Introduces 2022 Outlook
March 09, 2022 08:00 ET
|
P3 Health Partners, Inc.
Strong revenue growth of 46% for the fourth quarter and 32% for full year 2021 Full year 2022 revenue expected to be up to $1 billion, a 56% increase vs. prior year At-risk Medicare Advantage...
P3 Health Partners to Participate at Upcoming Investor Conferences
March 07, 2022 08:30 ET
|
P3 Health Partners, Inc.
HENDERSON, Nev., March 07, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners, Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today...
P3 Health Partners Expands to California, Closes Acquisition of Medcore HP and Omni IPA Medical Group, Inc.
January 04, 2022 08:00 ET
|
P3 Health Partners, Inc.
HENDERSON, Nev., Jan. 04, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners, Inc. (P3) (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced the closing...
P3 Health Partners Announces Participation at the 40th Annual J.P. Morgan Healthcare Conference
December 29, 2021 08:00 ET
|
P3 Health Partners Inc.
HENDERSON, Nev., Dec. 29, 2021 (GLOBE NEWSWIRE) -- P3 Health Partners Inc. (NASDAQ: PIII, or “P3”), a patient-centered and physician-led population health management company, today announced that...
P3 Health Partners Closes Business Combination with Foresight Acquisition Corp. and Will Begin Trading on the Nasdaq
December 03, 2021 17:24 ET
|
P3 Health Group LLC
NEW YORK, Dec. 03, 2021 (GLOBE NEWSWIRE) -- P3 Health Partners (“P3” or “Company”), a patient-centered and physician-led population health management company, announced today that it has closed its...